SurveillanceCoronavirus-COVID-19HealthNewsScientific/Medical StudiesVaccine Injury-deathVaccines

COVID-19 Vaccine mRNA Now Found in Breastmilk

(by Techno Fog | The Reactionary) – A small but groundbreaking study (available here) has been released at the Journal of the American Medical Association (JAMA) Pediatrics, demonstrating that trace amounts of COVID-19 vaccine mRNA were found in the breastmilk of lactating women as soon as one hour after vaccination.

This study was conducted from February to October 2020 (more on that in a moment), and included only 11 lactating women, 5 of whom received the Moderna vaccine and 6 of whom received the Pfizer vaccine. The comparison was made between their pre-vaccine breastmilk (the control) and post-vaccine breastmilk.

The results? The breastmilk of 5 out of 11 women tested had detectable COVID-19 vaccine mRNA in their breastmilk. For those keeping score, that is 45% – nearly half – of the study group.

The mRNA was detected in breastmilk as early as 1 hour after vaccination, and as late as 45 hours after vaccination.

Of course, given the limited sample size, this doesn’t mean that the COVID-19 vaccine mRNA will be absent from breastmilk after 45 hours. We’ve already seen that the spike protein/mRNA can last for months after vaccination . According to one study summarized by Dr. Robert Malone:

the mRNA and the spike protein produced persists for weeks in lymph node germinal centers in human patients. Immunohistochemical staining for spike antigen in mRNA vaccinated patient LNs varied between individuals, but showed abundant spike protein in germinal centers 16 days post-2nd dose, with spike antigen still present as late as 60 days post-2nd dose. Having worked with mRNA for decades, I can attest that this is highly unusual.

Back to the study. According to the authors:

“These data demonstrate for the first time to our knowledge the biodistribution of COVID-19 vaccine mRNA to mammary cells and the potential ability of tissue EVs to package the vaccine mRNA that can be transported to distant cells.”

They speculate that following the administration of a COVID-19 vaccine, “lipid nanoparticles containing the vaccine mRNA are carried to mammary glands via hematogenous and/or lymphatic routes.” Read Full Article >

You may also like

Leave a Comment